PatientsVille.com Logo

PatientsVille

Zyprexa Side Effects

Common Zyprexa Side Effects

The most commonly reported Zyprexa side effects (click to view or check a box to report):

Diabetes Mellitus (2314)
Weight Increased (1179)
Hypertension (846)
Pancreatitis (713)
Blood Triglycerides Increased (658)
Hyperglycaemia (595)
Overdose (591)
Metabolic Disorder (573)
Diabetes Mellitus Non-insulin-dependent (543)
Diabetic Ketoacidosis (524)
Blood Cholesterol Increased (517)
Obesity (438)
Prescribed Overdose (399)
Blood Cholesterol Abnormal (398)
Blood Glucose Increased (367)
Diabetic Coma (339)
Off Label Use (337)
Death (336)
Fall (288)
Anxiety (276)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Zyprexa Side Effects Reported to FDA

The following Zyprexa reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Zyprexa on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Schizoaffective Disorder Bipolar Type, Prescribed Overdose
on Mar 12, 2014 Male from US , 50 years of age, was diagnosed with and was treated with Zyprexa. Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: schizoaffective disorder bipolar type, prescribed overdose. Zyprexa dosage: N/A. Patient was hospitalized.

Suicidal Ideation, Depression
Patient was taking Zyprexa. Patient felt the following Zyprexa side effects: suicidal ideation, depression on Mar 11, 2014 from US Additional patient health information: Male , 54 years of age, was diagnosed with and. Zyprexa dosage: 2.5 Mg, Each Evening.

Portal Vein Cavernous Transformation, Mesenteric Vein Thrombosis
Adverse event was reported on Mar 11, 2014 by a Female taking Zyprexa (Dosage: 10 Mg, Qd) was diagnosed with and. Location: FR , 61 years of age, weighting 83.78 lb, After Zyprexa was administered, patient encountered several Zyprexa side effects: portal vein cavernous transformation, mesenteric vein thrombosis.

Haematoma, Anxiety, Anger, Influenza Like Illness, Dyspnoea, Visual Impairment, Lymphadenopathy, Nasopharyngitis, Neck Pain
on Mar 06, 2014 Female from NL , 33 years of age, weighting 116.8 lb, was diagnosed with and was treated with Zyprexa. Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: haematoma, anxiety, anger, influenza like illness, dyspnoea, visual impairment, lymphadenopathy, nasopharyngitis, neck pain. Zyprexa dosage: 10 Mg, Qd.


Nystagmus, Off Label Use
on Mar 06, 2014 Female from DE , 16 years of age, was treated with Zyprexa. Patient felt the following Zyprexa side effects: nystagmus, off label use. Zyprexa dosage: 10 Mg, Each Morning. Patient was hospitalized.

Injury, Congenital Anomaly
Patient was taking Zyprexa. After Zyprexa was administered, patient encountered several Zyprexa side effects: injury, congenital anomaly on Mar 04, 2014 from US Additional patient health information: Female , 69 years of age, weighting 150.0 lb, was diagnosed with and. Zyprexa dosage: N/A.

Hypophagia, Oligodipsia, Weight Decreased, Blood Potassium Decreased, Prescribed Overdose
Adverse event was reported on Mar 03, 2014 by a Female taking Zyprexa (Dosage: N/A) was diagnosed with and. Location: NZ , 53 years of age, Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: hypophagia, oligodipsia, weight decreased, blood potassium decreased, prescribed overdose. Patient was hospitalized.

Weight Increased, Hyperhidrosis
on Mar 05, 2014 Female from NL , 45 years of age, weighting 169.8 lb, was diagnosed with and was treated with Zyprexa Velotab. Patient felt the following Zyprexa side effects: weight increased, hyperhidrosis. Zyprexa Velotab dosage: 15 Mg, Qd.
Multiple prescriptions taken:
  • Temazepam (10 Mg, Qd)
  • Seresta (10 Mg, Prn)


Dysarthria, Disorientation, Amnesia, Coma, Confusional State, Extrapyramidal Disorder, Sedation, Toxicity To Various Agents
on Feb 27, 2014 Female from NZ , 72 years of age, was diagnosed with and was treated with Zyprexa Relprevv. After Zyprexa was administered, patient encountered several Zyprexa side effects: dysarthria, disorientation, amnesia, coma, confusional state, extrapyramidal disorder, sedation, toxicity to various agents. Zyprexa Relprevv dosage: 405 Mg, 4 Weekly.
Multiple concurrent drugs taken:
  • Carbamazepine (200 Mg, Bid)
  • Levothyroxine (100 Mg, Qd)
  • Thiamine (100 Mg, Qd)
Patient was hospitalized.

Mania, Neuroleptic Malignant Syndrome
Patient was taking Zyprexa. Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: mania, neuroleptic malignant syndrome on Feb 27, 2014 from JP Additional patient health information: Male , 55 years of age, was diagnosed with and. Zyprexa dosage: 5 Mg, Unk. Patient was hospitalized.

Renal Failure, Extrapyramidal Disorder, Somnolence, Toxicity To Various Agents, Haemodynamic Instability
Adverse event was reported on Feb 26, 2014 by a Female taking Zyprexa (Dosage: 10 Mg, Qd) . Location: FR , 62 years of age, Patient felt the following Zyprexa side effects: renal failure, extrapyramidal disorder, somnolence, toxicity to various agents, haemodynamic instability.
Multiple prescriptions taken:
  • Teralhite
  • Lexomil (1.5 Mg, Qd)
  • Venlafaxine (37.5 Mg, Bid)
  • Lamaline /01708901/ (1 Df, Bid)
  • Perindopril
  • Crestor
  • Bisoprolol Fumarate
  • Kardegic
Patient was hospitalized.


on Mar 14, 2014 Female from JP , 48 years of age, was diagnosed with and was treated with Zyprexa. . Zyprexa dosage: 10 Mg, Unk.
Multiple concurrent drugs taken:
  • Rohypnol (Unk Mg, Unk)
  • Lendormin (Unk Mg, Unk)
  • Serenace (Unk)
  • Akineton /00079501/ (Unk)


Pituitary Tumour
on Feb 21, 2014 Female from DE , 73 years of age, was treated with Zyprexa. Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: pituitary tumour. Zyprexa dosage: N/A.
Associated medications used:
  • Seroquel
Patient was hospitalized.

Dizziness, Amnesia, Tinnitus, Depression, Asthenia, Fatigue, Bruxism, Unevaluable Event
Patient was taking Zyprexa. Patient felt the following Zyprexa side effects: dizziness, amnesia, tinnitus, depression, asthenia, fatigue, bruxism, unevaluable event on Feb 19, 2014 from US Additional patient health information: Male , 53 years of age, weighting 190.0 lb, . Zyprexa dosage: N/A.
Multiple prescriptions taken:
  • Ultram
Patient was hospitalized and became disabled.

Status Epilepticus, Grand Mal Convulsion, Dyspnoea, Dystonia, Memory Impairment, Muscle Rigidity, Speech Disorder, Drooling
Adverse event was reported on Feb 20, 2014 by a Male taking Zyprexa (Dosage: N/A) . Location: SE , 21 years of age, After Zyprexa was administered, patient encountered several Zyprexa side effects: status epilepticus, grand mal convulsion, dyspnoea, dystonia, memory impairment, muscle rigidity, speech disorder, drooling.
Multiple concurrent drugs taken:
  • Cisordinol Acutard
Patient was hospitalized and became disabled.

Neurological Decompensation, Underweight, Dyskinesia, Grimacing, Migraine, Peripheral Coldness, Gastrooesophageal Reflux Disease, Platelet Count Decreased, Mastication Disorder
on Feb 20, 2014 Male from US , 23 years of age, weighting 105.0 lb, was diagnosed with and was treated with Zyprexa Zydis. Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: neurological decompensation, underweight, dyskinesia, grimacing, migraine, peripheral coldness, gastrooesophageal reflux disease, platelet count decreased, mastication disorder. Zyprexa Zydis dosage: N/A.

Depression Suicidal, Neutropenia, Phlebitis
on Feb 18, 2014 Female from FR , 64 years of age, was treated with Zyprexa. Patient felt the following Zyprexa side effects: depression suicidal, neutropenia, phlebitis. Zyprexa dosage: N/A. Patient was hospitalized.

Thrombosis, Muscle Injury, Prescribed Overdose
Patient was taking Zyprexa. After Zyprexa was administered, patient encountered several Zyprexa side effects: thrombosis, muscle injury, prescribed overdose on Mar 18, 2014 from US Additional patient health information: Male , 39 years of age, was diagnosed with and. Zyprexa dosage: 12.5 Mg, Qd. Patient was hospitalized.

Condition Aggravated, Transaminases Increased
Adverse event was reported on Feb 12, 2014 by a Male taking Zyprexa (Dosage: N/A) . Location: FR , 69 years of age, Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: condition aggravated, transaminases increased.
Associated medications used:
  • Ciflox /00697201/
  • Efient
  • Tenormine
  • Kardegic
  • Inexium /01479302/
  • Tahor
  • Atacand
  • Tienam


Coma, Disturbance In Attention, Circulatory Collapse, Oxygen Saturation Decreased, Hypothermia, Pneumonia Aspiration
on Feb 13, 2014 Female from FR , 36 years of age, was treated with Zyprexa. Patient felt the following Zyprexa side effects: coma, disturbance in attention, circulatory collapse, oxygen saturation decreased, hypothermia, pneumonia aspiration. Zyprexa dosage: N/A.
Multiple prescriptions taken:
  • Valium /00017001/
  • Stilnox
  • Depakine /00228502/
  • Tercian /00759301/
  • Levomepromazine
  • Seroplex
  • Relpax
  • Ketum (1 Df, Prn)
Patient was hospitalized.

Altered State Of Consciousness, Suicidal Ideation, Weight Increased, Facial Paresis, Balance Disorder, Disorientation, Delirium, Occult Blood, Visual Impairment
on Mar 17, 2014 Male from DE , 28 years of age, was diagnosed with and was treated with Zyprexa. After Zyprexa was administered, patient encountered several Zyprexa side effects: altered state of consciousness, suicidal ideation, weight increased, facial paresis, balance disorder, disorientation, delirium, occult blood, visual impairment. Zyprexa dosage: N/A.

Weight Decreased, Fall, Head Injury, Laceration, Crying, Fatigue
Patient was taking Zyprexa. Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: weight decreased, fall, head injury, laceration, crying, fatigue on Feb 05, 2014 from US Additional patient health information: Female , 26 years of age, weighting 105.0 lb, was diagnosed with and. Zyprexa dosage: N/A.
Associated medications used:
  • Remeron
  • Depakote
  • Neurontin
  • Ativan
  • Trazadone


Water Intoxication
Adverse event was reported on Mar 18, 2014 by a Male taking Zyprexa (Dosage: 10 Mg, Qd) was diagnosed with and. Location: JP , weighting 140.0 lb, Patient felt the following Zyprexa side effects: water intoxication.

Vaginal Haemorrhage
on Feb 03, 2014 Female from PT , 56 years of age, was treated with Zyprexa Velotab. After Zyprexa was administered, patient encountered several Zyprexa side effects: vaginal haemorrhage. Zyprexa Velotab dosage: N/A.

Fall
on Jan 31, 2014 Female from US , 57 years of age, weighting 202.0 lb, was diagnosed with and was treated with Zyprexa. Directly after, patient experienced the unwanted or unexpected Zyprexa side effects: fall. Zyprexa dosage: By Mouth.
Associated medications used:
  • Citalopram
  • Hbr
  • Clonazepam


1 of 444 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Zyprexa Side Effects

    Did You Have a Zyprexa Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Zyprexa for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative ZYPREXA Names:OLANZAPIN

    Active Ingredient: OLANZAPIN

    Zyprexa Dosage, Warnings, Usage.

    Side Effects reported to FDA: 11086

    Zyprexa safety alerts: 2014 2010 2005 2004 2002

    Reported deaths: 2077

    Reported hospitalizations: 5835

    Zyprexa (olanzapine): Use in Adolescents

    Audience: Neuropsychiatric healthcare professionals

    [Posted 01/29/2010] Lilly and FDA notified healthcare professionals of changes to the Prescribing Information for Zyprexa related to its indication for use in adolescents (ages 13-17) for treatment of schizophrenia and bipolar I disorder [manic or mixed episodes]. The revised labeling states that:

    Section 1, Indications and Usage: When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and hyperlipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents.

    Section 17.14, Need for comprehensive Treatment Program in Pediatric Patients: Zyprexa is indicated as an integral part of a total treatment program for pediatric patients with schizophrenia and bipolar disorder that may include other measures (psychological, educational, social) for patients with the disorder. Effectiveness and safety of ZYPREXA have not been established in pediatric patients less than 13 years of age.

    [01/04/2010 - Dear Healthcare Professional Letter - Lilly]
    [12/2009 - Prescribing Information - Lilly]

    Latest Zyprexa clinical trials